Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 5/2022

01-04-2022 | COVID-19 | Concise Research Report

Improving Colorectal Cancer Screening at an Employer-Sponsored Health Plan During the COVID-19 Pandemic

Authors: Jeniffer S. Kim, PhD, MPH, Omar Bakr, MD, MPH, Mimi Xu, MD, Michael Hochman, MD, MPH, Veronica M. Pagán, MA, MPH

Published in: Journal of General Internal Medicine | Issue 5/2022

Login to get access

Excerpt

As the COVID-19 pandemic increased in intensity, many United States medical centers halted non-urgent and elective medical procedures1, including colorectal cancer (CRC) screenings2 which already have poor screening rates prior to the pandemic.3 Recent US studies have shown the effectiveness of using mailed fecal immunochemical tests (FITs) programs to increase CRC screening rates.4, 5 Given the limited resources during the pandemic and low CRC screening, our academic medical center launched a CRC screening initiative, and we report on the results of this initiative and the characteristics of those who received screening through this program. …
Literature
1.
2.
3.
4.
5.
6.
Metadata
Title
Improving Colorectal Cancer Screening at an Employer-Sponsored Health Plan During the COVID-19 Pandemic
Authors
Jeniffer S. Kim, PhD, MPH
Omar Bakr, MD, MPH
Mimi Xu, MD
Michael Hochman, MD, MPH
Veronica M. Pagán, MA, MPH
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 5/2022
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-022-07426-3

Other articles of this Issue 5/2022

Journal of General Internal Medicine 5/2022 Go to the issue

Perspective

The Abrupt Expansion of Ambulatory Telemedicine: Implications for Patient Safety

Clinical Vignette

Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report

Original Research

The Ecology of Medical Care During the COVID-19 Pandemic in Japan: a Nationwide Survey

Clinical Vignette

Ketamine Cystitis: An Underrecognized Cause of Dysuria

Original Research

Associations of Chronic Medication Adherence with Emergency Room Visits and Hospitalizations

Letter to the Editor

COVID-19 and Elevated D-Dimer: A Tale of Caution
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits